Atlas Trials

Safety, Efficacy and Pharmacokinetics of XKDCT023 in DLBCL

Clinical trial NCT05269914 · UNKNOWN

Trial details

NCT number
NCT05269914
Sponsor
The Affiliated Hospital of Qingdao University
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Diffuse Large B Cell Lymphoma
Start date
2022-04-01
Primary completion
2022-12-31
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.